Cargando…
The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study
Various commercial anti-Spike SARS-CoV-2 antibody tests are used for studies and in clinical settings after vaccination. An international standard for SARS-CoV-2 antibodies has been established to achieve comparability of such tests, allowing conversions to BAU/mL. This study aimed to investigate th...
Autores principales: | Perkmann, Thomas, Mucher, Patrick, Perkmann-Nagele, Nicole, Radakovics, Astrid, Repl, Manuela, Koller, Thomas, Schmetterer, Klaus G., Bigenzahn, Johannes W., Leitner, Florentina, Jordakieva, Galateja, Wagner, Oswald F., Binder, Christoph J., Haslacher, Helmuth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865567/ https://www.ncbi.nlm.nih.gov/pubmed/35196824 http://dx.doi.org/10.1128/spectrum.01402-21 |
Ejemplares similares
-
Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222
por: Perkmann, Thomas, et al.
Publicado: (2021) -
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
por: Perkmann, Thomas, et al.
Publicado: (2021) -
Serum antibody response to BNT162b2 after natural SARS‐CoV‐2 infection
por: Perkmann, Thomas, et al.
Publicado: (2021) -
Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology
por: Perkmann, Thomas, et al.
Publicado: (2023) -
Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results
por: Perkmann, Thomas, et al.
Publicado: (2021)